市場調查報告書 - 217851

子宮肌瘤:全球臨床實驗檢討

Uterine Fibroids Global Clinical Trials Review, H2, 2012
出版商 GlobalData
出版日期 2012年07月24日 內容資訊 英文 Pages: 103
價格
子宮肌瘤:全球臨床實驗檢討 Uterine Fibroids Global Clinical Trials Review, H2, 2012
出版日期: 2012年07月24日 內容資訊: 英文 Pages: 103
簡介

本報告提供全球各國子宮肌瘤臨床實驗相關調查，彙整各地區、進展狀況、各階段、各募集情況的實驗量，代表性贊助商，正在開發的治療藥物的資訊，各企業機關的進行狀況等資訊，為您概述為以下內容。

目錄

簡介

子宮肌瘤 本報告的內容架構

不同地區的臨床實驗數量

  • 各國臨床實驗數量
    • 亞太地區主要國家
    • 歐洲的主要國家
    • 北美主要國家
    • 中東·非洲的主要國家
    • 中南美的主要國家

金磚四國的臨床實驗數量

G7各國的臨床實驗數量

  • G7各國的臨床實驗數量:各進展狀況

E7各國的臨床實驗數量

  • E7各國的臨床實驗數量:各進展狀況

不同階段臨床實驗數量

  • 進行中的臨床實驗數量:不同階段

各進展狀況臨床實驗數量

尚未完成的臨床實驗數量

一定期間內採用的實驗人數數

著名的贊助商

  • 參加著子宮肌瘤臨床實驗的著名的贊助商

著名的治療藥物比較

臨床實驗簡介

  • 主要企業臨床實驗概況
    • Repros Therapeutics Inc.
    • Abbott Laboratories
    • PregLem SA
    • Pfizer Inc.
    • 武田藥品工業
    • Mediterranea Medica S.L.
    • GAAD Medical Research Institute Inc
    • Laboratorios Litaphar, S.A.
    • BioPro Pharmaceutical, Inc.
    • HRA Pharma, SA
    • Halt Medical, Inc.
    • Bayer AG
    • GlaxoSmithKline plc
  • 主要大學·研究機關·醫院臨床實驗概況
    • Ullevaal University Hospital
    • Imperial College London
    • Taipei Veterans General Hospital
    • Mayo Clinic
    • Huazhong University of Science & Technology
    • Poitiers University Hospital
    • Mount Sinai School of Medicine
    • University of Manitoba
    • The Cleveland Clinic
    • Seoul National University Hospital
    • University of Sao Paulo
    • Northwestern University
    • Catholic University of the Sacred Heart
    • Sun Yat-sen University
    • National Taiwan University Hospital
    • Bayside Health
    • Sunnybrook Health Sciences Centre
    • Karolinska Institutet
    • Chinese University of Hong Kong
    • University of California, Davis

5個有代表性的臨床實驗簡介

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄

Abstract

Uterine Fibroids Global Clinical Trials Review, H2, 2012

Summary

GlobalData's clinical trial report, "Uterine Fibroids Global Clinical Trials Review, H2, 2012" provides data on the Uterine Fibroids clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Uterine Fibroids. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Uterine Fibroids. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

  • Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each, along with the clinical trial scenario in BRIC nations
  • Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
  • Listings of discontinued trials (suspended, withdrawn and terminated)

Reasons to buy

  • Understand the dynamics of a particular indication in a condensed manner
  • Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
  • Obtain discontinued trial listing for trials across the globe
  • Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies

Keywords

Uterine Fibroids Clinical Trials, Trial Designs, Subjects Recruited, Unaccomplished Trials of Uterine Fibroids, Pfizer, AstraZeneca, Novartis, GlaxoSmithKline, Sanofi, Eli Lilly and Company, Johnson & Johnson, Merck & Co., Inc, Bristol-Myers Squibb Company, Abbott Laboratories, Hoffmann-La Roche Ltd., Celgene Corporation, Daiichi Sankyo Company, Ltd., Bayer AG, Eisai Inc., GE Healthcare, Biogen Idec Inc., Copharos Inc., Wyeth Pharmaceuticals Inc., National Cancer Center, The University of Texas, M.D. Andersons, Vanderbilt Medical Center, Memorial Sloan Kettering Cancer Center, Cancer Research UK, North Central Cancer Group, Robert H. Lurie Comprehensive Cancer Center of Northwestern University, Fred Hutchinson Cancer Research Center, European Organization for Research and Treatment of Cancer, Dana-Farber Cancer Institute, The Cancer and Leukemia Group B, Columbia University, UCLA's Jonsson Comprehensive Cancer Center, Case Comprehensive Cancer Center, Mayo Clinic, Duke University, Ohio State University, National Cancer Center, University of Pennsylvania.

TOC

Table of Contents

Table of Contents 2

  • List of Tables 4
  • List of Figures 6
  • Introduction 7
  • Uterine Fibroids 7
  • Report Guidance 7
  • Clinical Trials by Region 8
  • Clinical Trials by Country 9
  • Top Five Countries Contributing to Clinical Trials in Asia-Pacific 11
  • Top Five Countries Contributing to Clinical Trials in Europe 12
  • Top Countries Contributing to Clinical Trials in North America 13
  • Top Countries Contributing to Clinical Trials in Middle East and Africa 14
  • Top Countries Contributing to Clinical Trials in Central and South America 15
  • Clinical Trials by BRIC Nations 16
  • Clinical Trials by G7 Nations 17
  • Clinical Trials in G7 Nations by Trial Status 18
  • Clinical Trials by E7 Nations 19
  • Clinical Trials in E7 Nations by Trial Status 20
  • Clinical Trials by Phase 21
  • In Progress Trials by Phase 22
  • Clinical Trials by Trial Status 23
  • Unaccomplished Trials of Uterine Fibroids 24
  • Subjects Recruited Over a Period of Time 27
  • Prominent Sponsors 28
  • Top Companies Participating in Uterine Fibroids Therapeutics Clinical Trials 30
  • Prominent Drug Comparison 32
  • Clinical Trial Profiles 33
  • Clinical Trial Overview of Top Companies 33
  • Repros Therapeutics Inc. 33
  • Clinical Trial Overview of Repros Therapeutics Inc. 33
  • Abbott Laboratories 35
  • Clinical Trial Overview of Abbott Laboratories 35
  • PregLem SA 36
  • Clinical Trial Overview of PregLem SA 36
  • Pfizer Inc. 37
  • Clinical Trial Overview of Pfizer Inc. 37
  • Takeda Pharmaceutical Company Limited 38
  • Clinical Trial Overview of Takeda Pharmaceutical Company Limited 38
  • Mediterranea Medica S.L. 39
  • Clinical Trial Overview of Mediterranea Medica S.L. 39
  • GAAD Medical Research Institute Inc 40
  • Clinical Trial Overview of GAAD Medical Research Institute Inc 40
  • Laboratorios Litaphar, S.A. 41
  • Clinical Trial Overview of Laboratorios Litaphar, S.A. 41
  • BioPro Pharmaceutical, Inc. 42
  • Clinical Trial Overview of BioPro Pharmaceutical, Inc. 42
  • HRA Pharma, SA 43
  • Clinical Trial Overview of HRA Pharma, SA 43
  • Halt Medical, Inc. 44
  • Clinical Trial Overview of Halt Medical, Inc. 44
  • Bayer AG 45
  • Clinical Trial Overview of Bayer AG 45
  • GlaxoSmithKline plc 46
  • Clinical Trial Overview of GlaxoSmithKline plc 46
  • Clinical Trial Overview of Top Universities / Institutes / Hospitals 47
  • Ullevaal University Hospital 47
  • Clinical Trial Overview of Ullevaal University Hospital 47
  • Imperial College London 48
  • Clinical Trial Overview of Imperial College London 48
  • Taipei Veterans General Hospital 49
  • Clinical Trial Overview of Taipei Veterans General Hospital 49
  • Mayo Clinic 50
  • Clinical Trial Overview of Mayo Clinic 50
  • Huazhong University of Science & Technology 51
  • Clinical Trial Overview of Huazhong University of Science & Technology 51
  • Poitiers University Hospital 52
  • Clinical Trial Overview of Poitiers University Hospital 52
  • Mount Sinai School of Medicine 53
  • Clinical Trial Overview of Mount Sinai School of Medicine 53
  • University of Manitoba 54
  • Clinical Trial Overview of University of Manitoba 54
  • The Cleveland Clinic 55
  • Clinical Trial Overview of The Cleveland Clinic 55
  • Seoul National University Hospital 56
  • Clinical Trial Overview of Seoul National University Hospital 56
  • University of Sao Paulo 57
  • Clinical Trial Overview of University of Sao Paulo 57
  • Northwestern University 58
  • Clinical Trial Overview of Northwestern University 58
  • Catholic University of the Sacred Heart 59
  • Clinical Trial Overview of Catholic University of the Sacred Heart 59
  • Sun Yat-sen University 60
  • Clinical Trial Overview of Sun Yat-sen University 60
  • National Taiwan University Hospital 61
  • Clinical Trial Overview of National Taiwan University Hospital 61
  • Bayside Health 62
  • Clinical Trial Overview of Bayside Health 62
  • Sunnybrook Health Sciences Centre 63
  • Clinical Trial Overview of Sunnybrook Health Sciences Centre 63
  • Karolinska Institutet 64
  • Clinical Trial Overview of Karolinska Institutet 64
  • Chinese University of Hong Kong 65
  • Clinical Trial Overview of Chinese University of Hong Kong 65
  • University of California, Davis 66
  • Clinical Trial Overview of University of California, Davis 66
  • Five Key Clinical Profiles 67

Appendix 100

  • Abbreviations 100
  • Definitions 100
  • Research Methodology 101
  • Secondary Research 101
  • About GlobalData 102
  • Contact Us 102
  • Disclaimer 102
  • Source 103

List of Tables

List of Tables

  • Uterine Fibroids Therapeutics Market, Global, Clinical Trials by Zone, 2012* 8
  • Uterine Fibroids Therapeutics Market, Global, Clinical Trials by Top Countries, 2012* 9
  • Uterine Fibroids Therapeutics Market, Global, Clinical Trials In Progress by Top Countries, 2012* 10
  • Uterine Fibroids Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2012* 11
  • Uterine Fibroids Therapeutics Clinical Trials, Europe, Top Five Countries, 2012* 12
  • Uterine Fibroids Therapeutics Clinical Trials, North America, Top Countries, 2012* 13
  • Uterine Fibroids Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2012* 14
  • Uterine Fibroids Therapeutics Clinical Trials, Central and South America, Top Countries, 2012* 15
  • Uterine Fibroids Therapeutics Clinical Trials, BRIC Countries, 2012* 16
  • Uterine Fibroids Therapeutics Clinical Trials, G7 Countries, 2012* 17
  • Uterine Fibroids Therapeutics Market, G7 Countries, Clinical Trials by Trial Status, 2012* 18
  • Uterine Fibroids Therapeutics Clinical Trials, E7 Countries, 2012* 19
  • Uterine Fibroids Therapeutics Market, E7 Countries, Clinical Trials by Trial Status, 2012* 20
  • Uterine Fibroids Therapeutics Market, Global, Clinical Trials by Phase, 2012* 21
  • Uterine Fibroids Therapeutics Market, Global, Clinical Trials In Progress by Phase 2012* 22
  • Uterine Fibroids Therapeutics Market, Global, Clinical Trials by Trial Status, 2012* 23
  • Uterine Fibroids Therapeutics Market, Global, Withdrawn Clinical Trials, 2012* 24
  • Uterine Fibroids Therapeutics Market, Global, Terminated Clinical Trials, 2012* 25
  • Uterine Fibroids Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2006-2011 27
  • Uterine Fibroids Therapeutics Clinical Trials, Global, Key Sponsors, 2012* 29
  • Uterine Fibroids Therapeutics Clinical Trials, Global, Top Companies by Phase, 2012* 31
  • Uterine Fibroids Therapeutics Clinical Trials, Global, Clinical Trials by Prominent Drugs, 2012* 32
  • Uterine Fibroids Therapeutics Clinical Trials Market, Global, Clinical Trials by Repros Therapeutics Inc., 2012* 33
  • Uterine Fibroids Therapeutics Clinical Trials Market, Global, Clinical Trials by Abbott Laboratories, 2012* 35
  • Uterine Fibroids Therapeutics Clinical Trials Market, Global, Clinical Trials by PregLem SA, 2012* 36
  • Uterine Fibroids Therapeutics Clinical Trials Market, Global, Clinical Trials by Pfizer Inc., 2012* 37
  • Uterine Fibroids Therapeutics Clinical Trials Market, Global, Clinical Trials by Takeda Pharmaceutical Company Limited, 2012* 38
  • Uterine Fibroids Therapeutics Clinical Trials Market, Global, Clinical Trials by Mediterranea Medica S.L., 2012* 39
  • Uterine Fibroids Therapeutics Clinical Trials Market, Global, Clinical Trials by GAAD Medical Research Institute Inc, 2012* 40
  • Uterine Fibroids Therapeutics Clinical Trials Market, Global, Clinical Trials by Laboratorios Litaphar, S.A., 2012* 41
  • Uterine Fibroids Therapeutics Clinical Trials Market, Global, Clinical Trials by BioPro Pharmaceutical, Inc., 2012* 42
  • Uterine Fibroids Therapeutics Clinical Trials Market, Global, Clinical Trials by HRA Pharma, SA, 2012* 43
  • Uterine Fibroids Therapeutics Clinical Trials Market, Global, Clinical Trials by Halt Medical, Inc., 2012* 44
  • Uterine Fibroids Therapeutics Clinical Trials Market, Global, Clinical Trials by Bayer AG, 2012* 45
  • Uterine Fibroids Therapeutics Clinical Trials Market, Global, Clinical Trials by GlaxoSmithKline plc, 2012* 46
  • Uterine Fibroids Therapeutics Clinical Trials Market, Global, Clinical Trials by Ullevaal University Hospital, 2012* 47
  • Uterine Fibroids Therapeutics Clinical Trials Market, Global, Clinical Trials by Imperial College London, 2012* 48
  • Uterine Fibroids Therapeutics Clinical Trials Market, Global, Clinical Trials by Taipei Veterans General Hospital, 2012* 49
  • Uterine Fibroids Therapeutics Clinical Trials Market, Global, Clinical Trials by Mayo Clinic, 2012* 50
  • Uterine Fibroids Therapeutics Clinical Trials Market, Global, Clinical Trials by Huazhong University of Science & Technology, 2012* 51
  • Uterine Fibroids Therapeutics Clinical Trials Market, Global, Clinical Trials by Poitiers University Hospital, 2012* 52
  • Uterine Fibroids Therapeutics Clinical Trials Market, Global, Clinical Trials by Mount Sinai School of Medicine, 2012* 53
  • Uterine Fibroids Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Manitoba, 2012* 54
  • Uterine Fibroids Therapeutics Clinical Trials Market, Global, Clinical Trials by The Cleveland Clinic, 2012* 55
  • Uterine Fibroids Therapeutics Clinical Trials Market, Global, Clinical Trials by Seoul National University Hospital, 2012* 56
  • Uterine Fibroids Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Sao Paulo, 2012* 57
  • Uterine Fibroids Therapeutics Clinical Trials Market, Global, Clinical Trials by Northwestern University, 2012* 58
  • Uterine Fibroids Therapeutics Clinical Trials Market, Global, Clinical Trials by Catholic University of the Sacred Heart, 2012* 59
  • Uterine Fibroids Therapeutics Clinical Trials Market, Global, Clinical Trials by Sun Yat-sen University, 2012* 60
  • Uterine Fibroids Therapeutics Clinical Trials Market, Global, Clinical Trials by National Taiwan University Hospital, 2012* 61
  • Uterine Fibroids Therapeutics Clinical Trials Market, Global, Clinical Trials by Bayside Health, 2012* 62
  • Uterine Fibroids Therapeutics Clinical Trials Market, Global, Clinical Trials by Sunnybrook Health Sciences Centre, 2012* 63
  • Uterine Fibroids Therapeutics Clinical Trials Market, Global, Clinical Trials by Karolinska Institutet, 2012* 64
  • Uterine Fibroids Therapeutics Clinical Trials Market, Global, Clinical Trials by Chinese University of Hong Kong, 2012* 65
  • Uterine Fibroids Therapeutics Clinical Trials Market, Global, Clinical Trials by University of California, Davis, 2012* 66

List of Figures

List of Figures

  • Uterine Fibroids Therapeutics Market, Global, Clinical Trials by Zone (%), 2012* 8
  • Uterine Fibroids Therapeutics Market, Global, Clinical Trials by Top Countries, 2012* 9
  • Uterine Fibroids Therapeutics Market, Global, Clinical Trials In Progress by Top Countries, 2012* 10
  • Uterine Fibroids Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2012* 11
  • Uterine Fibroids Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2012* 12
  • Uterine Fibroids Therapeutics Clinical Trials, North America, Top Countries (%), 2012* 13
  • Uterine Fibroids Therapeutics Clinical Trials, Central and South America, Top Countries (%), 2012* 15
  • Uterine Fibroids Therapeutics Clinical Trials, BRIC Countries (%), 2012* 16
  • Uterine Fibroids Therapeutics Clinical Trials, G7 Countries (%), 2012* 17
  • Uterine Fibroids Therapeutics Market, G7 Countries, Clinical Trials by Trial Status, 2012* 18
  • Uterine Fibroids Therapeutics Clinical Trials, E7 Countries (%), 2012* 19
  • Uterine Fibroids Therapeutics Market, E7 Countries, Clinical Trials by Trial Status, 2012* 20
  • Uterine Fibroids Therapeutics Market, Global, Clinical Trials by Phase (%), 2012* 21
  • Uterine Fibroids Therapeutics Market, Global, Clinical Trials In Progress by Phase, 2012* 22
  • Uterine Fibroids Therapeutics Market, Global, Clinical Trials by Trial Status, 2012* 23
  • Uterine Fibroids Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2006-2011 27
  • Uterine Fibroids Therapeutics Clinical Trials, Global, Key Sponsors, 2012* 28
  • Uterine Fibroids Therapeutics Clinical Trials, Global, Top Companies by Phase, 2012* 30
  • Uterine Fibroids Therapeutics Clinical Trials, Global, Clinical Trials by Prominent Drugs, 2012* 32
  • GlobalData Methodology 101

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

子宮肌瘤:全球臨床實驗檢討是由出版商GlobalData在2012年07月24日所出版的。這份市場調查報告書包含Pages: 103 價格從美金2500起跳。
Back to Top
;